Prophylactic antimicrobial therapy regimens(n) | Death(n) | Graft loss(n) | Patient and graft survival(n) |
---|---|---|---|
Tigecycline+ imipenem / meropenem (8/20) | 3 | 2 | 3 |
CAZ-AVI + meropenem (5/20) | 0 | 0 | 5 |
CAZ-AVI as initial therapy (4/20) | 0 | 0 | 4 |
CAZ-AVI as salvage therapy (3/20) | 0 | 1 | 2 |